Category: Include on Menu
-
Meta and BlackRock Partner on $14 Billion Texas Data Centre Development
Meta Platforms (NASDAQ:META) and BlackRock (NYSE:BLK) have agreed to form a joint venture to develop and own a major data centre campus in El Paso, Texas, in a project with an estimated total development cost of approximately $14 billion. The agreement brings together Meta’s expanding artificial intelligence infrastructure plans with BlackRock’s infrastructure investment capabilities. BlackRock…
-
PayPal Beats Second-Quarter Expectations and Lifts Full-Year Profit Forecast
PayPal (NASDAQ:PYPL) delivered stronger-than-expected second-quarter results, exceeding Wall Street forecasts for both earnings and revenue while increasing its profit outlook for the full year. Adjusted earnings per share came in at $1.38, comfortably ahead of analysts’ expectations of $1.28. Revenue reached $8.68 billion, representing 3% growth on a currency-neutral basis and surpassing the consensus forecast…
-
Stellantis Agrees Sale of Free2move Car-Sharing Business to Strengthen Automotive Focus
Stellantis (NYSE:STLA) has reached an agreement to sell its Free2move car-sharing business to German investment firm Mutares, as Chief Executive Antonio Filosa continues to streamline the group’s operations and concentrate on its core automotive business. The transaction, whose financial terms have not been disclosed, is expected to be completed before the end of the year.…
-
Expro Misses Earnings Estimates but Issues Stronger Revenue Outlook
Expro Group Holdings N.V. (NYSE:XPRO) reported mixed second-quarter results on Tuesday, missing Wall Street earnings expectations while delivering a modest revenue beat. Despite the earnings shortfall, the company issued stronger guidance for the second half of the year. Shares were little changed in after-hours trading following the announcement. Adjusted earnings per share came in at…
-
JetBlue Shares Rise After Second-Quarter Earnings Beat and New 2028 Profit Target
JetBlue Airways Corporation (NASDAQ:JBLU) reported better-than-expected second-quarter results on Tuesday, beating analyst forecasts for both earnings and revenue while unveiling a long-term earnings target under its JetForward transformation strategy. Shares rose 2.5% in pre-market trading following the announcement. The airline posted an adjusted loss of $0.66 per share, outperforming the analyst consensus estimate of a…
-
American Tower Beats Second-Quarter Estimates but Revenue Outlook Misses Expectations
American Tower Corporation (NYSE:AMT) reported stronger-than-expected second-quarter results on Tuesday, beating Wall Street forecasts for both earnings and revenue. However, investors were disappointed by the company’s full-year revenue guidance, which came in below market expectations despite an improved outlook. The communications infrastructure real estate investment trust posted adjusted earnings per share of $1.86, comfortably ahead…
-
GE Vernova Wins Contract to Modernise Dinorwig Hydropower Plant in Wales
GE Vernova (NYSE:GEV) has secured a contract from First Hydro Company, a joint venture between ENGIE and La Caisse, to replace two pumped storage generating units at the Dinorwig pumped storage hydropower station in North Wales. The project forms part of a long-term modernisation programme designed to extend the operational life of one of the…
-
CMS Energy Shares Decline After Second-Quarter Earnings Miss
CMS Energy (NYSE:CMS) reported weaker-than-expected second-quarter results on Tuesday, missing Wall Street estimates for both earnings and revenue, although the utility reaffirmed its full-year outlook and outlined strategic changes aimed at simplifying its business. Shares fell 3.07% in pre-market trading following the earnings release. Adjusted earnings per share came in at $0.37, well below the…
-
ProMIS Neurosciences Shares Climb on Positive Interim Alzheimer’s Trial Safety Results
ProMIS Neurosciences Inc. (NASDAQ:PMN) shares gained 13% on Tuesday after the company released encouraging six-month interim safety and biomarker data from its ongoing PRECISE-AD Phase 1b study evaluating PMN310 in patients with Alzheimer’s disease. The clinical-stage biotechnology company reported favourable blinded interim findings, highlighting a strong safety profile and biomarker trends that support continued development…
-
Pentair Shares Drop After Revenue Miss Overshadows Earnings Beat
Pentair plc (NYSE:PNR) reported second-quarter results on Tuesday that exceeded earnings expectations, but weaker-than-expected revenue and a soft near-term outlook weighed on investor sentiment, sending the company’s shares lower in pre-market trading. Shares of the water treatment and flow solutions company fell 5.03% following the earnings release. Adjusted earnings per share came in at $1.14,…